Principles of clinical pharmacology /

Saved in:
Bibliographic Details
Edition:Third edition.
Imprint:San Diego : Academic Press, Elsevier, 2012.
Description:xxi, 626 pages : illustrations ; 29 cm
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/10357049
Hidden Bibliographic Details
Other authors / contributors:Atkinson, Arthur J., Jr., editor.
ISBN:9780123854711 (hardback)
0123854717 (hardback)
Notes:Includes bibliographical references.
Summary:Principles of Clinical Pharmacology is a successful survey covering the pharmacologic principles underlying the individualization of patient therapy and contemporary drug development. This essential reference continues to focus on the basics of clinical pharmacology for the development, evaluation, and clinical use of pharmaceutical products while also addressing the most recent advances in the field. Written by leading experts in academia, industry, clinical and regulatory settings, the third edition has been thoroughly updated to provide readers with an ideal reference covering the wide range of important topics impacting clinical pharmacology as the discipline plays an increasingly significant role in drug development and regulatory science. Includes new chapters on imaging and the pharmacogenetic basis of adverse drug reactions. Offers an expanded regulatory section that addresses US and international issues and guidelines. Provides extended coverage of earlier chapters on transporters, pharmacogenetics and biomarkers and also illustrates the impact of gender on drug response. Presents a broadened discussion of clinical trials from Phase 1 to incorporate Phases II and III.
Table of Contents:
  • Preface
  • Chapter 1. Introduction
  • Part 1. Pharmacokinetics
  • Chapter 2. Clinical pharmacokinetics
  • Chapter 3. ComPartmental analysis of drug distribution
  • Chapter 4. Drug absorption and bioavailability
  • Chapter 5. Effects of renal disease on pharmacokinetics
  • Chapter 6. Kinetics of hemodialysis and hemofiltration
  • Chapter 7. Effects of liver disease on pharmacokinetics
  • Chapter 8. NoncomPartmental vs. comPartmental approaches to pharmacokinetic analysis
  • Chapter 9. Distributed models of drug kinetics
  • Chapter 10. Population pharmacokinetics
  • Part 2. Drug Metabolism and Transport
  • Chapter 11. Pathways of drug metabolism
  • Chapter 12. Biochemical mechanisms of drug toxicity
  • Chapter 13. Chemical assay of drugs and drug metabolites
  • Chapter 14. Equilibrative and concentrative transport
  • Chapter 15. Pharmacogenetics
  • Chapter 16. Drug interactions
  • Part 3. Assessment of Drug Effects
  • Chapter 17. Physiological and laboratory markers of drug effect
  • Chapter 18. Dose response and concentration response analysis
  • Chapter 19. Kinetics of pharmacologic effect
  • Chapter 20. Disease progression models
  • Part 4. Optimizing and Evaluating Patient Therapy
  • Chapter 21. Sex differences in pharmacokinetics and pharmacodynamics
  • Chapter 22. Drug therapy in pregnant and nursing women
  • Chapter 23. Drug therapy in neonates and pediatric patients
  • Chapter 24. Drug therapy in the elderly
  • Chapter 25. Clinical analysis of adverse drug reactions
  • Chapter 26. Quality assessment of drug therapy
  • Part 5. Drug Discovery and Development
  • Chapter 27. Project management
  • Chapter 28. Drug discovery
  • Chapter 29. Pre-clinical development
  • Chapter 30. Animal scale up
  • Chapter 31. Phase I studies
  • Chapter 32. PK and PD considerations in the development of biotechnology products and large molecules
  • Chapter 33. Design of clinical development programs
  • Chapter 34. Good design practices for clinical trials
  • Chapter 35. Role of the FDA in guiding drug development
  • Appendix I. Table of Laplace Transforms
  • Appendix II. Answers to Study Problems